5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | BUY | BUY | BUY | BUY |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 39.37▼ | 39.27▼ | 39.03▲ | 38.86▲ | 37.23▲ |
MA10 | 39.10▲ | 38.87▲ | 38.73▲ | 38.43▲ | 35.78▲ |
MA20 | 38.23▲ | 37.76▲ | 37.57▲ | 37.26▲ | 34.89▲ |
MA50 | 36.60▲ | 36.25▲ | 35.95▲ | 35.48▲ | 36.78▲ |
MA100 | 35.38▲ | 35.05▲ | 34.90▲ | 35.06▲ | 35.49▲ |
MA200 | 34.67▲ | 35.72▲ | 36.02▲ | 36.68▲ | 38.13▲ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.030▲ | 0.093▲ | 0.111▲ | 0.139▲ | 0.662▲ |
RSI | 71.422▲ | 72.320▲ | 72.835▲ | 73.927▲ | 67.089▲ |
STOCH | 92.324▲ | 89.530▲ | 89.512▲ | 90.143▲ | 90.364▲ |
WILL %R | -15.023▲ | -11.852▲ | -11.852▲ | -9.040▲ | -4.733▲ |
CCI | 47.045 | 69.869 | 85.958 | 98.616 | 177.179▲ |
BBANDS | $ALTL Bollinger Bands Expanding | Set Alert |
Thursday, July 10, 2025 06:13 AM
Explore Altimmune stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for ALT.
|
Wednesday, July 09, 2025 05:00 AM
Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead program is pemvidutide, a ...
|
Wednesday, July 09, 2025 04:01 AM
Altimmune, Inc. (NASDAQ:ALT) is one of Goldman Sachs’ top penny stock picks. On June 26, the company reported positive topline results from its Phase 2b IMPACT trial evaluating Pemvidutide, a ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
11/07/25 | 39.07 | 39.2366 | 39.07 | 39.12 | 13,186 |
10/07/25 | 39.15 | 39.5086 | 39.15 | 39.40 | 10,741 |
09/07/25 | 38.81 | 38.93 | 38.705 | 38.8706 | 12,398 |
08/07/25 | 38.57 | 38.7538 | 38.45 | 38.651 | 9,346 |
07/07/25 | 38.49 | 38.65 | 38.05 | 38.25 | 33,904 |
03/07/25 | 38.60 | 38.82 | 38.60 | 38.74 | 26,750 |
02/07/25 | 37.76 | 38.37 | 37.76 | 38.37 | 9,339 |
01/07/25 | 37.59 | 37.8726 | 37.27 | 37.71 | 14,657 |
30/06/25 | 37.65 | 37.75 | 37.63 | 37.66 | 12,582 |
27/06/25 | 37.50 | 37.76 | 37.27 | 37.52 | 12,301 |
|
|
||||
|
|
||||
|
|